SCHEMBL6310815

SCHEMBL6310815

Cc1ccc(C2CCC(c3ccc(C)cc3)[N]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM1A O60341 1/20 0.38
MAPT P10636 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
CYP19A1 P11511 2/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
SLC18A3 Q16572 1/20 0.34
HTT P42858 2/20 0.34
RAB9A P51151 2/20 0.34
ALDH1A1 P00352 1/20 0.34
THRB P10828 1/20 0.34
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310539 0.75 SLC6A2 (0.42) ACHESLC6A2SLC6A4SLC6A3RAB9A
SCHEMBL5537503 0.73 CYP19A1 (0.36) ACHETDP1KDM1AMAPTHTR2A
SCHEMBL1405569 0.70 ESR2 (0.50) ACHETDP1MAPTHTR2AHTR2C
SCHEMBL7794528 0.70 ALDH1A1 (0.40) MAPTCYP19A1KMT2ASLC18A3RAB9A
SCHEMBL38651941 0.69 MAOB (0.39) ACHEKDM1AMEN1KMT2AALDH1A1
SCHEMBL2537599 0.67 SLC18A3 (0.52) ACHETDP1MAPTSLC18A3HTT
SCHEMBL43080 0.67 SLC18A3 (0.56) ACHETDP1MAPTSLC18A3HTT
SCHEMBL23722780 0.66 KDM1A (0.33) ACHETDP1KDM1AMAPTHTR2A
SCHEMBL23891752 0.65 PDE5A (0.32) HTR2AHTR2CHTR2BCYP19A1THRB
SCHEMBL8025878 0.65 LMNA (0.59) TDP1MAPTKMT2ASLC18A3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6916893-B2 Polymerization-active transition metal complexes having bulky ligand systems SER. V. GMBH (DE) 2005-07-12 US claimed
US-20040171774-A1 Polymerization-active transition metal complexes having bulky ligand systems RIEGER BERNHARD (DE) 2004-09-02 US claimed
US-6916893-B2 Polymerization-active transition metal complexes having bulky ligand systems SER. V. GMBH (DE) 2005-07-12 US disclosed
US-20040171774-A1 Polymerization-active transition metal complexes having bulky ligand systems RIEGER BERNHARD (DE) 2004-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171774-A1 Polymerization-active transition metal complexes having bulky ligand systems AP1M1, CCNC, CLTB ACHE 4396/4885TDP1 3418/4885KDM1A 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.